Navigation Links
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
Date:11/4/2009

ical development programs.

Revenue for the three month period ended September 30, 2009 was $10.2 million compared to revenue of $21.4 million in the third quarter of 2008. Revenue year-to-date September 30, 2009 was $32.9 million as compared to revenue of $61.8 million in the same period in 2008. This decrease in revenue is largely the result of lower contract research and manufacturing revenues primarily resulting from the sale of certain of the company's pulmonary assets to Novartis which occurred on December 31, 2008.

Cash, cash equivalents, and short-term investments at September 30, 2009 were $275.7 million. Not included in this cash balance is the cash payment of $125 million received from AstraZeneca in October 2009 as a result of the collaboration for NKTR-118 and NKTR-119.

Conference Call to Discuss Third Quarter 2009 Financial Results

A conference call to review results will be held today, Wednesday, November 4, 2009 at 2 PM Pacific Time.

Details are below:

Howard Robin, president and chief executive officer, and John Nicholson, chief financial officer, will host a conference call beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT) on Wednesday, November 4, 2009.

To access the conference call, follow these instructions:

Dial: 866-356-3095 (U.S.); 617-597-5391 (international)

Passcode: 27967367

An audio replay will also be available shortly following the call through Wednesday, November 18, 2009 and can be accessed by dialing 888-286-8010 (U.S.); or 617-801-6888 (international) with a passcode of 60261022.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expertise have enabled nine approved products in the U.S. or Europe for
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Host Conference Call to Discuss Todays Announcement of a New Partnership for NKTR-118 and NKTR-119
3. AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
4. Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
5. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
7. Nektar Therapeutics Reports First Quarter 2009 Financial Results
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
9. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
10. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
11. Nektar Announces Retirement of Irwin Lerner from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... the University of Delaware, is known worldwide for ... environmental sustainability and electronics. , His early academic ... well-defined, crystalline structure. At the atomic scale, their ... can separate molecules with size differences of merely ... nanometer), making them useful to the chemical and ...
(Date:7/24/2014)... July 24, 2014 Your cell ... in modeling lithium-ion battery storage capacity. , New ... a theoretical model created at Lawrence Livermore ... that predicts how carbon components will perform as ... emphasizes the urgent need for higher-performance batteries. Several ...
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
(Date:7/24/2014)... July 24, 2014 The first part ... Escalation in First in Human Studies” will cover comprehensive ... go/no-go decisions. , With increasing R&D costs and declining ... need to maximize the knowledge collected in early Phase ... improve success in late stage development. , Next, the ...
Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... conversion of sunlight to electricity could brighten the ... National Laboratory (Berkeley Lab) have found a new ... place in semiconductor thin-films. This new route to ... continues to plague conventional solid-state solar cells. ...
... ... its 6th annual student award program. , ... SAN DIEGO, CA (Vocus) March 30, 2010 ... for Environmental Health & Sciences Foundation (AEHS Foundation) to recognize talented, emerging environmental ...
... genetic sleight of hand, researcher Xinyao Liu and professor ... coaxed photosynthetic microbes to secrete oilbypassing energy and cost ... appear in this week,s advanced online issue of the ... or PNAS . The challenges of ...
Cached Biology Technology:New path to solar energy via solid-state photovoltaics 2New path to solar energy via solid-state photovoltaics 3Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders 2Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders 3Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders 4Microbes reprogrammed to ooze oil for renewable biofuel 2Microbes reprogrammed to ooze oil for renewable biofuel 3
(Date:7/24/2014)... Neiker-Tecnalia is currently conducting research into the potato genes ... characterised by a reduction in rainfall and increased extremes ... the most resistant genes in order to create new ... conditions.The research is also seeking to find out how ... of greater drought and higher and lower temperatures. , ...
(Date:7/24/2014)... in German . ... asthma sufferers worldwide, a further 600 million people living ... global population contending with allergic rhinitis (allergic inflammation of ... other organs and parts of the body beyond the ... the form of inflammatory bowel diseases such as colitis ...
(Date:7/24/2014)... release is available in German . ... to recognize and respond to threats to health, and ... detailed understanding of the mechanism underlying immunologic memory, however, ... have converged to support the hypothesis that the persistence ... cells with stem-cell-like potential. Until now, there was no ...
Breaking Biology News(10 mins):Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3
... 2012 -- Over the past 30 years, numerous studies ... such as bipolar disorder, schizophrenia, anxiety disorder and dementia. ... causes behavior disorders in a range of mammals and ... patients, but study results have been inconsistent. Now, ...
... People who have Ulcerative Colitis (UC) or Ileal ... their time between flares is crucial to successfully living ... combination of drugs, dietary changes and, for many, the ... the dietary management of these conditions. Now, Sigma-Tau Pharmaceuticals, ...
... across the globe are trying to develop plans to ... footprint by reducing the associated greenhouse gas emissions. While ... more energy efficient lighting, windows, and building systems, deeper ... a rethinking of how future infrastructure and energy policies ...
Cached Biology News:Does Borna disease virus cause mental illness? 2Maker of VSL#3 probiotic offers assistance program for ulcerative colitis and ileal pouch patients 2Columbia engineers map energy use in NYC buildings 2Columbia engineers map energy use in NYC buildings 3
... Immunogen: Immunogen corresponds to amino ... human SKAP55.,PA1-525 has been successfully used in ... By Western blot, this antibody detects an ... cells.This antibody has also been used in ...
... to suit the widest possible range of ... laboratory. Labware carriers can be placed at ... simple for the user, thanks to a ... correctly guided into position. This allows easy ...
... was developed in the late 1960s by ... the earliest commercial pioneers of immunoassay in ... in 1987. Sac-Cel rapidly found favour with ... "in house" radioimmunoassays, and became a benchmark ...
... (3-D-Gluconamidopropyl)deoxycholamide White solid. HYGROSCOPIC. A ... Has reduced electrostatic interactions that do not ... Aggregation number: 8-16. Purity: ≥95% by ... Aggregation number 8 - 16, CMC 1.1 ...
Biology Products: